OBJECTIVE:Smokers with depressive symptoms have more difficulty quitting smoking than the general population of smokers. The present study examines a web-based treatment using acceptance and commitment therapy (ACT) for smokers with depressive symptoms. The study aimed to determine participant receptivity to the intervention and its effects on smoking cessation, acceptance of internal cues, and depressive symptoms. METHODS:Smokers who had positive screening results for depressive symptoms at baseline (n = 94) were selected from a randomized controlled trial (N = 222) comparing web-based ACT for smoking cessation (WebQuit.org) with Smokefree.gov. Forty-five participants (48%) completed the three-month follow-up. RESULTS: Compared to Smokefree.gov, WebQuit participants spent significantly more time on site (p =.001) and had higher acceptance of physical cravings (p =.033). While not significant, WebQuit participants were more engaged and satisfied with their program and were more accepting of internal cues overall. There was preliminary evidence that WebQuit participants had higher quit rates (20% versus 12%) and lower depressive symptoms at follow-up (45% versus 56%) than those in Smokefree.gov. CONCLUSIONS: This was the first study of web-based ACT for smoking cessation among smokers with depressive symptoms, with promising evidence of receptivity, efficacy, impact on a theory-based change process, and possible secondary effects on depression. A fully powered trial of the ACT WebQuit.org intervention specifically for depressed smokers is needed. This was part of a clinical trial registered as NCT#01166334 at www.clinicaltrials.gov .
RCT Entities:
OBJECTIVE: Smokers with depressive symptoms have more difficulty quitting smoking than the general population of smokers. The present study examines a web-based treatment using acceptance and commitment therapy (ACT) for smokers with depressive symptoms. The study aimed to determine participant receptivity to the intervention and its effects on smoking cessation, acceptance of internal cues, and depressive symptoms. METHODS: Smokers who had positive screening results for depressive symptoms at baseline (n = 94) were selected from a randomized controlled trial (N = 222) comparing web-based ACT for smoking cessation (WebQuit.org) with Smokefree.gov. Forty-five participants (48%) completed the three-month follow-up. RESULTS: Compared to Smokefree.gov, WebQuit participants spent significantly more time on site (p =.001) and had higher acceptance of physical cravings (p =.033). While not significant, WebQuit participants were more engaged and satisfied with their program and were more accepting of internal cues overall. There was preliminary evidence that WebQuit participants had higher quit rates (20% versus 12%) and lower depressive symptoms at follow-up (45% versus 56%) than those in Smokefree.gov. CONCLUSIONS: This was the first study of web-based ACT for smoking cessation among smokers with depressive symptoms, with promising evidence of receptivity, efficacy, impact on a theory-based change process, and possible secondary effects on depression. A fully powered trial of the ACT WebQuit.org intervention specifically for depressed smokers is needed. This was part of a clinical trial registered as NCT#01166334 at www.clinicaltrials.gov .
Entities:
Keywords:
Acceptance and Commitment Therapy; smoking cessation; symptom of depression; web-based treatment
Authors: Ricardo F Muñoz; Leslie L Lenert; Kevin Delucchi; Jacqueline Stoddard; John E Perez; Carlos Penilla; Eliseo J Pérez-Stable Journal: Nicotine Tob Res Date: 2006-02 Impact factor: 4.244
Authors: Jonathan B Bricker; Sue L Mann; Patrick M Marek; Jingmin Liu; Arthur V Peterson Journal: Nicotine Tob Res Date: 2010-02-08 Impact factor: 4.244
Authors: Mónica Hernández-López; M Carmen Luciano; Jonathan B Bricker; Jesús G Roales-Nieto; Francisco Montesinos Journal: Psychol Addict Behav Date: 2009-12
Authors: Jaimee L Heffner; Jennifer B McClure; Kristin E Mull; Robert M Anthenelli; Jonathan B Bricker Journal: Bipolar Disord Date: 2015-04-25 Impact factor: 6.744
Authors: Sarah E Woolf-King; Madison Firkey; Jacklyn D Foley; Jonathan Bricker; Judith A Hahn; Elizabeth Asiago-Reddy; John Wikier; Dezarie Moskal; Alan Z Sheinfil; Jeremy Ramos; Stephen A Maisto Journal: AIDS Behav Date: 2022-03-18